These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 16973044)

  • 1. Hepatitis C (chronic).
    Mohsen A; Norris S
    Clin Evid; 2006 Jun; (15):1061-72. PubMed ID: 16973044
    [No Abstract]   [Full Text] [Related]  

  • 2. Chronic hepatitis C.
    Mohsen A; Norris S
    Clin Evid; 2005 Dec; (14):920-30. PubMed ID: 16620443
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of hepatitis C in HIV-coinfected patients at the CROI.
    Barreiro P
    AIDS Rev; 2004; 6(1):63. PubMed ID: 15168743
    [No Abstract]   [Full Text] [Related]  

  • 4. Characteristics of hepatitis C treatment with pegylated interferons and ribavirin.
    Jiménez-Méndez R; Castañeda-Hernández G
    Ann Hepatol; 2010; 9 Suppl():61-4. PubMed ID: 20713998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Protocol for the antiviral therapy of hepatitis C].
    Judit G; Gábor H; Béla H; Mihály M; Alajos P; Ferenc S; István T; László T; ;
    Orv Hetil; 2010 Jan; 151(2):66-72. PubMed ID: 20061235
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment with pegylated interferon and ribavirin in patients co-infected by human immunodeficiency virus and hepatitis C virus].
    Marcos Sánchez F; Albo Castaño MI; Casallo Blanco S
    Rev Clin Esp; 2007 Mar; 207(3):150-1; author reply 151-2. PubMed ID: 17397643
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment strategies of acute and chronic hepatitis C].
    Gładysz A; Inglot M
    Przegl Epidemiol; 2002; 56 Suppl 5():10-5. PubMed ID: 15553066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Long-acting interferon: studies on pegylated interferon].
    Ma H; Wang H
    Zhonghua Gan Zang Bing Za Zhi; 2002 Feb; 10(1):78-9. PubMed ID: 11856520
    [No Abstract]   [Full Text] [Related]  

  • 9. Hepatitis C treatment, HAART and side effects.
    TreatmentUpdate; 2001; 13(7):7-8. PubMed ID: 11794865
    [No Abstract]   [Full Text] [Related]  

  • 10. [HIV/HCV double infection: combination is a clear therapy option].
    Reich B
    Dtsch Med Wochenschr; 2004 Jul; 129(28-29):1590. PubMed ID: 15274242
    [No Abstract]   [Full Text] [Related]  

  • 11. Scleromyxedema secondary to hepatitis C virus and successfully treated with antiviral therapy.
    Smith JA; Kalimullah FA; Erickson CP; Peng LS
    Dermatol Online J; 2015 Sep; 21(9):. PubMed ID: 26437283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pegylated interferon-alpha2a and ribavirin in HIV-hepatitis C coinfected patients.
    Expert Rev Anti Infect Ther; 2004 Jun; 2(3):341-2. PubMed ID: 15490503
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of hepatitis C in children.
    Aziz S
    J Coll Physicians Surg Pak; 2005 Jun; 15(6):317-8. PubMed ID: 15924831
    [No Abstract]   [Full Text] [Related]  

  • 14. Interferon for hepatitis C patients with psychiatric disorders.
    Asnis GM; De La Garza R; Rego SA; Henderson MA; Reinus JF
    Am J Psychiatry; 2004 Dec; 161(12):2332; author reply 2332-4. PubMed ID: 15569920
    [No Abstract]   [Full Text] [Related]  

  • 15. Peginterferon alfa-2b and ribavirin in thalassaemia/chronic hepatitis C virus-co-infected non-responder to standard interferon-based.
    Hamidah A; Thambidorai CR; Jamal R
    Med J Malaysia; 2005 Oct; 60(4):517-9. PubMed ID: 16570722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [ANRS HC 02 RIBAVIC: from multicenter trial to daily practice].
    Pol S
    Gastroenterol Clin Biol; 2009 Mar; 33 Suppl 2():S91-3. PubMed ID: 19375041
    [No Abstract]   [Full Text] [Related]  

  • 17. Interferon for hepatitis C patients with psychiatric disorders.
    Rifai MA; Bozorg B; Rosenstein DL
    Am J Psychiatry; 2004 Dec; 161(12):2331-2; author reply 2332-4. PubMed ID: 15569919
    [No Abstract]   [Full Text] [Related]  

  • 18. Hepatitis C virus infection.
    Bacon BR; Di Bisceglie AM
    N Engl J Med; 2001 Nov; 345(19):1425-6; author reply 1427-8. PubMed ID: 11794183
    [No Abstract]   [Full Text] [Related]  

  • 19. High relapse rate seen at week 72 for patients treated with R1626 combination therapy.
    Pockros P; Nelson D; Godofsky E; Rodriguez-Torres M; Everson GT; Fried MW; Ghalib R; Harrison S; Nyberg L; Shiffman ML; Chan A; Hill G
    Hepatology; 2008 Oct; 48(4):1349-50. PubMed ID: 18821613
    [No Abstract]   [Full Text] [Related]  

  • 20. Second thoughts about secondary analyses.
    Ferenci P
    Dig Liver Dis; 2005 Oct; 37(10):805-7; author reply 808-9. PubMed ID: 16023903
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.